Advertisement

Prognostic Significance of Increased Left Ventricular Mass Index to Mortality and Sudden Death in Patients With Stable Coronary Heart Disease (from the Heart and Soul Study)

      Data are limited about the significance of left ventricular (LV) hypertrophy or mass in patients with coronary heart disease (CHD), particularly in the setting of normal ejection fraction (EF). The association of LV mass index with all-cause mortality and sudden death in a cohort with CHD was evaluated. Using transthoracic echocardiography, LV mass normalized to body surface area was measured in 1,016 subjects with stable CHD. Cox proportional hazards models were used to examine the association of LV mass index and LV hypertrophy (LV mass index >95 g/m2 in women and >115 in men) with time to death and time to sudden or arrhythmic death. Mean LV mass index was 101 ± 27 g/m2 in men and 88 ± 23 in women. During a mean follow-up of 3.55 years, there were 146 deaths and 34 sudden or arrhythmic deaths. Total mortality was higher in subjects with LV hypertrophy (25% vs 11%, p <0.001), as was mortality from sudden or arrhythmic death (6.7% vs 2.2%, p = 0.001). After adjustment for age, gender, cardiovascular risk factors, and medical therapy, LV hypertrophy was associated with both all-cause mortality (hazard ratio 2.0, p <0.001) and sudden or arrhythmic death (hazard ratio 3.1, p = 0.003). Findings were similar in the subgroup with EF ≥55% (mortality hazard ratio 1.8, p = 0.02; sudden and arrhythmic death hazard ratio 3.1, p = 0.02). Analyzed as a continuous variable, every 20-unit increase in LV mass index increased the adjusted hazard of death by 22% (p = 0.001) and adjusted hazard of sudden or arrhythmic death by 40% (p = 0.004). In conclusion, in patients with stable CHD, increased LV mass index was independently associated with all-cause mortality and sudden or arrhythmic death, even in subjects with normal EF.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gardin J.
        • McClelland R.
        • Kitzman D.
        • Lima J.
        • Bommer W.
        • Klopfenstein H.
        • Wong N.
        • Smith V.
        • Gottdiener J.
        M-Mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study).
        Am J Cardiol. 2001; 87: 1051-1057
        • Verdecchia P.
        • Carini G.
        • Circo A.
        • Dovellini E.
        • Giovannini E.
        • Lombardo M.
        • Solinas P.
        • Gorini M.
        • Maggioni A.
        Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study.
        J Am Coll Cardiol. 2001; 38: 1829-1835
        • Haider A.W.
        • Larson M.G.
        • Benjamin E.J.
        • Levy D.
        Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death.
        J Am Coll Cardiol. 1998; 32: 1454-1459
        • Devereux R.B.
        • Lutas E.M.
        • Casale P.N.
        • Kligfield P.
        • Eisenberg R.R.
        • Hammond I.W.
        • Miller D.H.
        • Reis G.
        • Alderman M.H.
        • Laragh J.H.
        Standardization of M-mode echocardiographic left ventricular anatomic measurements.
        J Am Coll Cardiol. 1984; 4: 1222-1230
        • Lavie C.J.
        • Milani R.V.
        • Ventura H.O.
        • Messerli F.H.
        Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction.
        Am J Cardiol. 2006; 98: 1396-1399
        • Ruo B.
        • Rumsfeld J.
        • Hlatky M.
        • Liu H.
        • Browner W.
        • Whooley M.
        Depressive symptoms and health-related quality of life: the Heart and Soul Study.
        JAMA. 2003; 290: 215-221
        • Schiller N.
        • Shah P.
        • Crawford M.
        • DeMaria A.
        • Devereux R.
        • Feigenbaum H.
        • Gutgesell H.
        • Reichek N.
        • Sahn D.
        • Schnittger I.
        • et al.
        Recommendations for quantitation of the left ventricle by two-dimensional echocardiography.
        J Am Soc Echocardiogr. 1989; 2: 358-367
        • Lang R.
        • Bierig M.
        • Devereux R.
        • Flachskampf F.
        • Foster E.
        • Pellikka P.
        • Picard M.
        • Roman M.
        • Seward J.
        • Shanewise J.
        Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.
        J Am Soc Echocardiogr. 2005; 18: 1440-1463
        • Hammond I.W.
        • Devereux R.B.
        • Alderman M.H.
        • Lutas E.M.
        • Spitzer M.C.
        • Crowley J.S.
        • Laragh J.H.
        The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension.
        J Am Coll Cardiol. 1986; 7: 639-650
        • Ang D.
        • Pringle S.
        • Struthers A.
        The cardiovascular risk factor, left ventricular hypertrophy, is highly prevalent in stable, treated angina pectoris.
        Am J Hypertens. 2007; 20: 1029-1035
        • Grambsch P.M.
        • Therneau T.M.
        Proportional hazards tests and diagnostics based on weighted residuals.
        Biometrika. 1994; 81: 515-526
        • Schoenfeld D.
        Partial residuals for the proportional hazards regression model.
        Biometrika. 1982; 69: 239-241
        • Stecker E.
        • Vickers C.
        • Waltz J.
        • Socoteanu C.
        • John B.
        • Mariani R.
        • McAnulty J.
        • Gunson K.
        • Jui J.
        • Chugh S.
        Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study.
        J Am Coll Cardiol. 2006; 47: 1161-1166
        • Singh J.
        • Hall W.
        • McNitt S.
        • Wang H.
        • Daubert J.
        • Zareba W.
        • Ruskin J.
        • Moss A.
        Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
        J Am Coll Cardiol. 2005; 46: 1712-1720
        • Choudhury L.
        • Mahrholdt H.
        • Wagner A.
        • Choi K.
        • Elliott M.
        • Klocke F.
        • Bonow R.
        • Judd R.
        • Kim R.
        Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy.
        J Am Coll Cardiol. 2002; 40: 2156-2164
        • Moon J.
        • McKenna W.
        • McCrohon J.
        • Elliott P.
        • Smith G.
        • Pennell D.
        Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.
        J Am Coll Cardiol. 2003; 41: 1561-1567
        • Spirito P.
        • Bellone P.
        • Harris K.
        • Bernabo P.
        • Bruzzi P.
        • Maron B.
        Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy.
        N Engl J Med. 2000; 342: 1778-1785
        • Barbier C.E.
        • Bjerner T.
        • Johansson L.
        • Lind L.
        • Ahlstrom H.
        Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group.
        J Am Coll Cardiol. 2006; 48: 765-771
        • Kon-No Y.
        • Watanabe J.
        • Koseki Y.
        • Koyama J.
        • Yamada A.
        • Toda S.
        • Shinozaki T.
        • Fukuchi M.
        • Miura M.
        • Kagaya Y.
        • Shirato K.
        Microvolt T wave alternans in human cardiac hypertrophy: electrical instability and abnormal myocardial arrangement.
        J Cardiovasc Electrophysiol. 2001; 12: 759-763